Korro Bio, Inc. (KRRO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $186.81M
Last updated: Nov 17, 2026 at 11:06 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 7.1% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 47.1, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about KRRO
News
KRRO Valuation
KRRO Profitability: Margins, ROIC and FCF
Korro Bio (KRRO) has an operating margin of -5891.0% and a net margin of 0.0%. It posts -82.8% ROIC and a -4943.8% FCF margin.
- Operating margin
- -5891.0%
- Net margin
- 0.0%
- ROIC
- -82.8%
- ROE
- -113.3%
- FCF margin
- -4943.8%
- FCF yield
- -28.1%
Korro Bio Competitors
The companies most similar to Korro Bio (KRRO) include Rocket Pharmaceuticals, ProQR Therapeutics BV and Precision BioSciences.
Sector: Healthcare
Companies most similar to Korro BioKRRO Analyst Ratings
Korro Bio (KRRO) has a Buy consensus from 11 analysts: 10 Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 11
- Strong Buy
- 2
- Buy
- 8
- Hold
- 1
- Sell
- 0
- Strong Sell
- 0
KRRO Bull Case vs Bear Case
Bull case
- KRRO beat EPS estimates in 87.5% of its last 8 reported quarters.
- 90.9% of KRRO's analyst ratings are Buy or Strong Buy.
Bear case
- KRRO's quarterly revenue changed -43.1% year over year.
KRRO Earnings: Beat Rate and Next Report
Korro Bio (KRRO) beat the EPS estimate in 7 of the last 8 quarters (87.5%). Its next report is expected on Mar 10, 2027.
- Beat rate
- 7 of 8 quarters (87.5%)
- Average surprise
- 15.0%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$1.38
KRRO Earnings Date
KRRO reports Mar 10, 2027. The date is estimated.
KRRO ETF Holders
GNG tracks 4 ETFs that hold KRRO. The largest weights:
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Health Care Index Fund ETF Shares (VHT), <0.01% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), <0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 5, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About KRRO
When does KRRO report earnings?
Korro Bio, Inc. (KRRO) is expected to report earnings on Mar 10, 2027.
Does KRRO pay dividends?
Korro Bio, Inc. (KRRO) does not currently pay a regular dividend.
What is KRRO's market cap?
Korro Bio, Inc. (KRRO) has a market capitalization of $186.81M with a current stock price of $12.71.
KRRO pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.